Clinical trial Recruiting at 2 sites Interventional Ages 18 and up

Evaluating the Autonomic Nervous System in Multiple Sclerosis Patients

Official title: Definition of Autonomic Nervous System Involvement in Patients With Relapsing-remitting and Primary Progressive Multiple Sclerosis

Run by Istituti Clinici Scientifici Maugeri SpA · NCT05748015 · Data updated 2026-11-12

This study is testing how the autonomic nervous system affects people with multiple sclerosis to see if understanding these changes can help improve their symptoms and treatment.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment60 (estimated)
SponsorIstituti Clinici Scientifici Maugeri SpA
Academic / other
Locations2 sites (Telese Terme, Benevento and 1 other locations)
StatusRecruiting
StartedMarch 4, 2021
Main results expectedNovember 30, 2026
Study endsMay 30, 2027
Registry record updatedApril 17, 2026
Trial IDNCT05748015 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include individuals diagnosed with relapsing-remitting or primary progressive multiple sclerosis.

Probably not a fit

Patients with other forms of multiple sclerosis or those with additional neurological disorders may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study aims to assess the involvement of the autonomic nervous system in patients with relapsing-remitting and primary progressive multiple sclerosis. It seeks to define characteristics of dysautonomia to enhance treatment strategies for managing symptoms like orthostatic hypotension and thermoregulation disorders. The study will utilize skin biopsies to quantify small nerve fibers and conduct cardiovascular reflex testing, alongside clinical scales to evaluate autonomic and pain symptoms. By understanding the correlation between autonomic dysfunction and disease progression, the study hopes to improve patient outcomes.

Why it matters

Potential benefit: If successful, this study could lead to improved management of autonomic symptoms in multiple sclerosis patients, enhancing their quality of life.

How similar studies have gone: While the specific approach may be novel, studies investigating autonomic nervous system involvement in multiple sclerosis have shown promising results.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* diagnosis of relapsing-remitting and primary progressive multiple sclerosis.

Exclusion Criteria:

* other forms of multiple sclerosis,
* known other neurological disorders
* assumption of potentially neurotoxic substances or drugs.

Where it's running

  • ICS Maugeri - IRCCS of Telese Terme
    Telese Terme, Benevento, Italy
    Recruiting
  • Department of Neurosciences, Reproductive Sciences and Odontostomatology, University of Naples Federico II
    Naples, Italy
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.